Asthma drug treats food allergy – Clinical Advisor

Asthma drug treats food allergy
Clinical Advisor
As Kari Nadeau, MD, PhD, and fellow investigators noted in their report in Allergy, Asthma & Clinical Immunology, pilot data have shown that omalizumab may hasten the person's ability to tolerate more than 4 g of food-allergen protein. The group
Perceived Stress Positively Linked to Allergy FlaresMonthly Prescribing Reference

all 4 news articles »

View full post on asthma – Google News

Comparison of clinical features in patients with eosinophilic esophagitis living in an urban and rural environment.

Related Articles

Comparison of clinical features in patients with eosinophilic esophagitis living in an urban and rural environment.

Dis Esophagus. 2014 Jan 2;

Authors: Lee YJ, Redd M, Bayman L, Frederickson N, Valestin J, Schey R

Abstract
Eosinophilic esophagitis (EoE) has been associated with exposure to aeroallergens. Living in different locations (urban vs. rural) could potentially expose individuals to different environmental factors. Currently, there is limited data on the matter, and all was based on small population studies that did not exclude proton pump inhibitor (PPI)-responsive esophageal eosinophilia in their cohort. The primary aim of this study was to determine the prevalence of EoE in an urban versus rural population and compare demographic and clinical characteristics in patients that had been treated with high-dose PPI prior to diagnosis. Esophageal biopsies were obtained from a cohort of patients who presented with symptoms of dysphagia, odynophagia, globus sensation, and heartburn during a 10-year period. Only patients who had biopsies from the mid and distal esophagus with ?20 eosinophils per high-power field while on high-dose PPI treatment during endoscopy were included. Urban population was defined as >1000 people/square mile, and rural population was defined as ?1000 people/square mile (U.S. Census Bureau). Demographic data from each group was analyzed for age, sex, body mass index, duration of symptoms, and tobacco use. Chi-square analysis was used for frequencies with statistical significance defined as P???0.05. A total of 20?718 patients were identified and their records evaluated. From this cohort, 57 (0.28%) symptomatic patients (male/female: 39/18, mean age = 29.5 years) had biopsy-proven EoE (?20 eosinophils/hpf) while on PPI treatment. Of those EoE patients, 29 (50.9%) reported living in rural area versus 28 (49.1%) living in the urban area. The most common medical history components included asthma (12.3%), and the most common presenting symptoms included dysphagia (50.9%), heartburn (26.3%), and nausea/vomiting (22.8%). The average duration of symptoms, body mass index, and smoking habits did not differ between the groups. Dysphagia was significantly more prevalent in the urban population (37.9% vs. 64.3% P = 0.047), while heartburn and reflux were more prevalent in the rural population (37.9% vs. 14.3 P = 0.043). Asthma was prevalent in both populations without a significant difference (P = not significant). There is no residential variation in the incidence of EoE among patients with non-PPI-responsive esophageal eosinophilia. Dysphagia was more prevalent in the urban population, while heartburn and reflux symptoms were more prevalent in the rural environment. Further exploration of environmental factors and specific allergens may help explain the varying symptoms and causes of EoE.

PMID: 24382218 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

New clinical trial shows increased asthma control with FeNO-guided anti … – News-Medical.net

New clinical trial shows increased asthma control with FeNO-guided anti
News-Medical.net
A total of 187 non-smoking asthma patients (18-64 years) with perennial allergy and on regular inhaled corticosteroid (ICS) treatment were recruited at 17 primary health care centres in Sweden, randomly assigned to two groups and followed for one year.
AEROCRINE AB : Aerocrine: First Primary Care Trial Supports FeNO-Guided 4-traders (press release)

all 3 news articles »

View full post on asthma – Google News

Clinical Assessment of Acupuncture for the Treatment of Chronic Asthma

Condition:   Asthma
Interventions:   Device: Verum acupuncture;   Device: Sham acupuncture
Sponsors:   Shanghai University of Traditional Chinese Medicine;   Shanghai University of Traditional Chinese Medicine;   Shanghai Municipal Health Bureau;   National Natural Science Foundation of China
Recruiting – verified August 2013

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

One in five children outgrow asthma – Clinical Advisor

One in five children outgrow asthma
Clinical Advisor
To better understand factors related to remission or persistence of childhood asthma, the researchers analyzed data from a 1996 survey that followed 248 Swedish children aged 7 to 8 years who had asthma. Participants were reassessed annually until age 
One in five kids may 'outgrow' asthmaMyFox Austin

all 5 news articles »

View full post on asthma – Google News

Asthma Global Clinical Trials Review, H1, 2013: New Research Report … – SBWire (press release)

Asthma Global Clinical Trials Review, H1, 2013: New Research Report
SBWire (press release)
Boston, MA — (SBWIRE) — 06/15/2013 — GlobalData's clinical trial report, "Asthma Global Clinical Trials Review, H1, 2013" provides data on the Asthma clinical trial scenario. This report provides elemental information and data relating to the

View full post on asthma – Google News